FSR vs NRIX
FSR (FSR) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
FSR (FSR) common stock.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
FSR does not have a complete income-statement cache yet.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
NRIX currently screens at market cap $1.77B.
Not investment advice. Open the FSR and NRIX stock pages for the full models.
Not investment advice.